PhaseBio Pharmaceuticals, Inc. (PHAS)
CapEx to Revenue
24734.56%
TTM · Retrieved:
PHAS CapEx to Revenue
Current (TTM)24734.56%retrieved
Current (TTM)24734.56%retrieved
PHAS CapEx/Revenue (0.00% → 24734.56%)
Latest values, visible window
High-resolution chart · PNG
PHAS capex to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 24,734.5582% | |
| 441.25% | |
| 40.6607% | |
| 17.8144% | |
| 0% | |
| 0% |